22157.jpg
Worldwide Sequencing Reagents Industry to 2028 - Increasing Demand for Third Generation Sequencing Presents Opportunities
July 23, 2021 04:28 ET | Research and Markets
Dublin, July 23, 2021 (GLOBE NEWSWIRE) -- The "Sequencing Reagents Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Technology; Application; Reagent Type; End User; Geography."...
22157.jpg
Global Gene Therapy Market 2021-2027 - COVID-19 Causes Gene Therapy Market to Buckle & Collapse
July 13, 2021 03:28 ET | Research and Markets
Dublin, July 13, 2021 (GLOBE NEWSWIRE) -- The "Gene Therapy - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global market for Gene Therapy...
22157.jpg
Global Genomics Market (2021 to 2026) - Growth, Trends, COVID-19 Impact, and Forecasts
May 19, 2021 06:03 ET | Research and Markets
Dublin, May 19, 2021 (GLOBE NEWSWIRE) -- The "Genomics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)" report has been added to ResearchAndMarkets.com's offering. The genomics...
22157.jpg
Global Whole Genome and Exome Sequencing Markets Report 2021-2025 - Industry on Verge of Breakout in Healthcare, Consumer and Agricultural Markets
April 13, 2021 06:53 ET | Research and Markets
Dublin, April 13, 2021 (GLOBE NEWSWIRE) -- The "Whole Genome and Exome Sequencing Markets by Research, Clinical, Tumor, Pathogen, Agribio & Consumer with Executive and Consultant Guides....
22157.jpg
World Genomic Cancer Panel and Profiling Markets by Cancer and Germline/Somatic 2021-2025: New Science Creating New Market Opportunities with Regularity
February 25, 2021 04:13 ET | Research and Markets
Dublin, Feb. 25, 2021 (GLOBE NEWSWIRE) -- The "Genomic Cancer Panel and Profiling Markets by Cancer and Germline/Somatic Type with Screening Potential Market Size, Customized Forecasting/Analysis,...
Breast Cancer Index™ demonstrates its ability to predict preferential endocrine benefit irrespective of risk for HR+ early-stage breast cancer patients
December 17, 2020 08:00 ET | Biotheranostics, Inc.
San Diego, CA, Dec. 17, 2020 (GLOBE NEWSWIRE) -- Evidence demonstrating the ability of Breast Cancer Index to predict preferential endocrine benefit irrespective of clinical risk for HR+ early-stage...
22157.jpg
World Whole Genome and Exome Sequencing Markets, 2021-2025: COVID-19 Drives Overnight Global Growth in Pathogen Sequencing - A New Industry Emerges.
December 16, 2020 10:43 ET | Research and Markets
Dublin, Dec. 16, 2020 (GLOBE NEWSWIRE) -- The "Whole Genome and Exome Sequencing Markets by Research, Clinical, Tumor, Pathogen, Agribio & Consumer with Executive and Consultant Guides....
22157.jpg
Global DNA Sequencing Market (2020 to 2025) - Growth, Trends, and Forecasts
December 09, 2020 07:18 ET | Research and Markets
Dublin, Dec. 09, 2020 (GLOBE NEWSWIRE) -- The "DNA Sequencing Market - Growth, Trends, and Forecasts (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering. Global DNA...
Biotheranostics appoints Mark D. Pegram, MD as Chief Medical Advisor of Breast Oncology
December 03, 2020 08:00 ET | Biotheranostics, Inc.
San Diego, CA, Dec. 03, 2020 (GLOBE NEWSWIRE) -- Biotheranostics announces Mark D. Pegram, MD as Chief Medical Advisor of Breast Oncology in support of Breast Cancer Index, the only commercially...